Literature DB >> 18756542

Response to bortezomib in refractory type I cryoglobulinemia.

Giampaolo Talamo, David Claxton, Guido Tricot, Louis Fink, Maurizio Zangari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18756542     DOI： 10.1002/ajh.21258

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature.

Authors:  Milena Tocut; Ziv Rozman; Alexander Biro; Asher Winder; Amir Tanay; Gisele Zandman-Goddard
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

Review 2.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

Review 3.  Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.

Authors:  Emilio Besada; Anders Vik; Wenche Koldingsnes; Johannes C Nossent
Journal:  Int J Hematol       Date:  2013-04-25       Impact factor: 2.490

4.  Resistant type II cryoglobulinaemic vasculitis successfully treated with bortezomib in a patient with SLE.

Authors:  Katherine Dutton; Sinisa Savic; Roger Owen; Edward Vital
Journal:  BMJ Case Rep       Date:  2019-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.